C12N 2799/06
In vitro
Official title: in vitro
C12N2799/06 (In vitro) appears on 38 US grants and 61 published applications in this corpus.
Search patents in C12N- Granted patents
- 38
- Published applications
- 61
- Assignees
- 38
- Inventors
- 94
- Latest grant
- 17 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 6 |
| 2004 | 1 | 2 |
| 2005 | 3 | 3 |
| 2006 | 0 | 2 |
| 2007 | 1 | 3 |
| 2008 | 2 | 9 |
| 2009 | 2 | 5 |
| 2010 | 3 | 4 |
| 2011 | 4 | 5 |
| 2012 | 3 | 2 |
| 2013 | 3 | 2 |
| 2014 | 0 | 2 |
| 2015 | 1 | 1 |
| 2016 | 2 | 2 |
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 1 | 3 |
| 2020 | 2 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 1 | 1 |
| 2024 | 2 | 2 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Phagemid vector17 Jun 2025US 12,331,308 B2Imperial College Innovations Limited
- Materials and methods for the manufacture of pluripotent stem cells14 May 2024US 11,981,932 B2Janssen Biotech, Inc.
- Method of treating aging-associated cognitive impairment by reducing CCR327 Feb 2024US 11,912,998 B2The Board of Trustees of the Leland Stanford Junior University
- Phagemid vector14 Mar 2023US 11,603,540 B2Imperial College Innovations Limited
- Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3)1 Feb 2022US 11,236,340 B2The Board of Trustees of the Leland Stanford Junior University
- Materials and methods for the manufacture of pluripotent stem cells31 Oct 2024US 2024/0360421 A1Janssen Biotech, Inc.
- Biomarkers of aging for detection and treatment of disorders13 Jun 2024US 2024/0191238 A1The Board of Trustees of the Leland Stanford Junior University
- Phagemid Vector24 Aug 2023US 2023/0265452 A1Imperial College Innovations Limited
- Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same7 Jul 2022US 2022/0213487 A1The Board of Trustees of the Leland Stanford Junior University
- Pancreatic endocrine cells, method for producing same, and transdifferentiation agent12 May 2022US 2022/0145261 A1Juntendo Educational Foundation
Most cited
By later US patents
- Methods of diagnosing, preventing and treating cancer metastasis44US 8,568,998 B2Whitehead Institute for Biomedical Research · 2013
- Method for the production of permanent human cell lines9US 9,315,773 B2Cevec Pharmaceuticals GmbH · 2016
- Proteinase inhibitor, precursor thereof and genetic sequences encoding same6US 6,946,278 B2Hexima Limited · 2005
- Proteinase inhibitor, precursor thereof and genetic sequences encoding same5US 6,031,087 AThe University of Melbourne · 2000
- Methods and compositions for reducing amyloid beta levels5US 7,951,367 B2The J. David Gladstone Institutes · 2011